Ami Navon
- Molecular Biology top 5%
- Cell Biology top 2%
- Physiology top 5%
- Epidemiology top 10%
- Oncology top 10%
- Co-authors
- Alfred L. GoldbergStewart H. LeckerMarcelo D. GomesR. Thomas JagoeAaron CiechanoverTamar ZivYael DavidArie Admon
- Topics
- Ubiquitin and proteasome pathways (22 papers)Endoplasmic Reticulum Stress and Disease (8 papers)Peptidase Inhibition and Analysis (7 papers)
- Journals
- Proceedings of the National Academy of SciencesJournal of Biological ChemistryMolecular Cell
- Partner nations
- IsraelUnited StatesGermany
In The Last Decade
Ami Navon
34 papers receiving 2.5k citations
Hit Papers
Peers
Comparison fields: 5 of 104
- Molecular Biology 2.2k
- Cell Biology 689
- Physiology 501
- Epidemiology 406
- Oncology 303
Countries citing papers authored by Ami Navon
This map shows the geographic impact of Ami Navon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ami Navon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ami Navon more than expected).
Fields of papers citing papers by Ami Navon
This network shows the impact of papers produced by Ami Navon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ami Navon. The network helps show where Ami Navon may publish in the future.
Co-authorship network of co-authors of Ami Navon
This figure shows the co-authorship network connecting the top 25 collaborators of Ami Navon. A scholar is included among the top collaborators of Ami Navon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ami Navon. Ami Navon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 4 | |
| 3 | 7 | |
| 4 | 14 | |
| 5 | 5 | |
| 6 | 2 | |
| 7 | 34 | |
| 8 | 51 | |
| 9 | 12 | |
| 10 | 33 | |
| 11 | 16 | |
| 12 | 53 | |
| 13 | 139 | |
| 14 | 12 | |
| 15 | 16 | |
| 16 | 37 | |
| 17 | 43 | |
| 18 | 173 | |
| 19 | 17 | |
| 20 | 5 |
About Ami Navon
Ami Navon is a scholar working on Cell Biology, Oncology and Molecular Biology, having authored 34 papers that have together received 2.6k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (22 papers), Endoplasmic Reticulum Stress and Disease (8 papers) and Peptidase Inhibition and Analysis (7 papers). The work is most often cited by research in Cell Biology (689 citations), Rehabilitation (255 citations) and Molecular Biology (2.2k citations). Ami Navon has collaborated with scholars based in Israel, United States and Germany. Frequent co-authors include Alfred L. Goldberg, Stewart H. Lecker, Marcelo D. Gomes, R. Thomas Jagoe, Aaron Ciechanover, Tamar Ziv, Yael David, Arie Admon, Boaz Tirosh and John J. Costanzi. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Molecular Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.